Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Amphastar Pharmaceuticals (AMPH) Non-cash Items (2016 - 2026)

Amphastar Pharmaceuticals has reported Non-cash Items over the past 13 years, most recently at $4.7 million for Q4 2025.

For Q4 2025, Non-cash Items fell 2.48% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 2.48%, while the annual FY2025 figure was $4.7 million, 2.48% down from the prior year.
Non-cash Items for Q4 2025 was $4.7 million at Amphastar Pharmaceuticals, down from $33.3 million in the prior quarter.
Over five years, Non-cash Items peaked at $327.2 million in Q4 2023 and troughed at $500000.0 in Q2 2021.
A 5-year average of $66.7 million and a median of $10.2 million in 2022 define the central range for Non-cash Items.
Biggest five-year swings in Non-cash Items: tumbled 98.64% in 2021 and later surged 5280.76% in 2023.
Year by year, Non-cash Items stood at $500000.0 in 2021, then skyrocketed by 2800.0% to $14.5 million in 2022, then surged by 2156.24% to $327.2 million in 2023, then tumbled by 98.52% to $4.9 million in 2024, then fell by 2.48% to $4.7 million in 2025.
Business Quant data shows Non-cash Items for AMPH at $4.7 million in Q4 2025, $33.3 million in Q3 2025, and $20.0 million in Q2 2025.